Gyre Therapeutics Inc (GYRE)

Schlusskurs vom Vortag:

$15.29

Offen:

$15.18

24-Stunden-Volumen:

63,073

Marktkapitalisierung:

$1.22B

Einnahmen:

-

Nettoeinkommen (Verlust:

-

KGV:

-

EPS:

-

Netto-Cashflow:

-

1W Leistung:

-3.91%

1M Leistung:

-10.10%

6M Leistung:

+0.00%

1J Leistung:

+0.00%

1-Tages-Spanne:

$13.71

$15.18

52-Wochen-Spanne:

$10.41

$27.10

Gyre Therapeutics Inc Stock (GYRE) Company Profile

Firmenname

Gyre Therapeutics Inc

Sektor

Healthcare (1209)

Branche

Biotechnology (699)

Telefon

650-871-0761

Adresse

611 GATEWAY BLVD., SUITE 710, SOUTH SAN FRANCISCO

Mitarbeiter

0

Twitter

Nächster Verdiensttermin

2024-06-12

Neueste SEC-Einreichungen

GYRE's Discussions on Twitter

Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2021-04-29	Fortgesetzt	Stephens	Overweight
2021-02-10	Eingeleitet	Piper Sandler	Overweight
2020-05-21	Eingeleitet	Raymond James	Outperform
2019-01-04	Eingeleitet	Oppenheimer	Outperform
2018-02-12	Bestätigt	B. Riley FBR, Inc.	Buy
2018-02-09	Bestätigt	Chardan Capital Markets	Buy
2017-12-08	Eingeleitet	B. Riley FBR, Inc.	Buy
2017-06-12	Eingeleitet	Chardan Capital Markets	Buy
2017-06-06	Eingeleitet	Ladenburg Thalmann	Buy
2016-06-30	Eingeleitet	Rodman & Renshaw	Buy

Alle ansehen

Gyre Therapeutics Inc Aktie (GYRE) Neueste Nachrichten

Gyre Therapeutics Reports First Quarter 2024 Earnings - Yahoo Finance

Yahoo Finance

Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire Inc.

Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update - Investing.com South Africa

Investing.com South Africa

Gyre Therapeutics exec sells shares worth over $282,000 By Investing.com - Investing.com Canada

Investing.com Canada

Public companies among Gyre Therapeutics, Inc.'s (NASDAQ:GYRE) largest shareholders, saw gain in holdings value after stock jumped 10% last week - Simply Wall St

Simply Wall St

Gyre Therapeutics Stock: Under The Radar Biotech Has A Shot At MASH Approval (NASDAQ:GYRE) - Seeking Alpha

Seeking Alpha

Finanzdaten der Gyre Therapeutics Inc-Aktie (GYRE)

Gyre Therapeutics Inc-Aktie (GYRE) Insiderhandel